Dr. Lal Pathlabs Limited - stock earnings
LALPATHLAB.BO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 845.0 million INR | 5.5 billion INR |
| 2023Q4 | 813.0 million INR | 5.4 billion INR |
| 2023Q3 | 1.1 billion INR | 6.0 billion INR |
| 2023Q2 | 826.0 million INR | 5.4 billion INR |
| 2023Q1 | 567.0 million INR | 4.9 billion INR |
| 2022Q4 | 528.0 million INR | 4.9 billion INR |
| 2022Q3 | 717.0 million INR | 5.3 billion INR |
| 2022Q2 | 577.0 million INR | 5.0 billion INR |
| 2022Q1 | 613.3 million INR | 4.9 billion INR |
| 2021Q4 | 573.0 million INR | 5.0 billion INR |
| 2021Q3 | 950.0 million INR | 5.0 billion INR |
| 2021Q2 | 1.3 billion INR | 6.1 billion INR |
| 2021Q1 | 834.2 million INR | 4.3 billion INR |
| 2020Q4 | 945.0 million INR | 4.5 billion INR |
| 2020Q3 | 853.0 million INR | 4.3 billion INR |
| 2020Q2 | 284.0 million INR | 2.7 billion INR |
| 2020Q1 | 325.4 million INR | 3.0 billion INR |
| 2019Q4 | 541.0 million INR | 3.3 billion INR |
| 2019Q3 | 805.0 million INR | 3.7 billion INR |
| 2019Q2 | 588.0 million INR | 3.4 billion INR |
| 2019Q1 | 470.8 million INR | 3.0 billion INR |
| 2018Q4 | 458.0 million INR | 2.9 billion INR |
| 2018Q3 | 570.0 million INR | 3.2 billion INR |
| 2018Q2 | 494.0 million INR | 2.9 billion INR |
| 2018Q1 | 401.0 million INR | 2.7 billion INR |
| 2017Q4 | 360.0 million INR | 2.6 billion INR |
| 2017Q3 | 506.0 million INR | 2.8 billion INR |
| 2017Q2 | 441.0 million INR | 2.5 billion INR |
| 2017Q1 | 309.9 million INR | 2.2 billion INR |
| 2016Q4 | 308.7 million INR | 2.1 billion INR |
| 2016Q3 | 525.1 million INR | 2.6 billion INR |
| 2016Q2 | 398.2 million INR | 2.2 billion INR |
| 2016Q1 | 344.4 million INR | 2.0 billion INR |
| 2015Q4 | 608.2 million INR | 1.9 billion INR |
| 2015Q3 | 61.9 million INR | 2.2 billion INR |
| 2015Q2 | 307.4 million INR | 1.9 billion INR |
| 2015Q1 | 273.0 million INR | 1.7 billion INR |
| 2014Q4 | 226.6 million INR | 1.6 billion INR |
LALPATHLAB.BO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 3.6 billion INR | 22.3 billion INR |
| 2023 | 2.4 billion INR | 20.2 billion INR |
| 2022 | 3.4 billion INR | 20.9 billion INR |
| 2021 | 2.9 billion INR | 15.8 billion INR |
| 2020 | 2.3 billion INR | 13.3 billion INR |
| 2019 | 2.0 billion INR | 12.0 billion INR |
| 2018 | 1.7 billion INR | 10.6 billion INR |
| 2017 | 1.5 billion INR | 9.1 billion INR |
| 2016 | 1.3 billion INR | 7.9 billion INR |
| 2015 | 942.4 million INR | 6.6 billion INR |
| 2014 | 795.9 million INR | 5.6 billion INR |
| 2013 | 551.3 million INR | 4.5 billion INR |
| 2012 | 447.1 million INR | 3.4 billion INR |
| 2011 | 291.2 million INR | 2.4 billion INR |
LALPATHLAB.BO
Price: ₹2,535.90
Dividend Yield: 1.08%
Forward Dividend Yield: 0.94%
Payout Ratio: 60.44%
Dividend Per Share: 24.00 INR
Earnings Per Share: 39.68 INR
P/E Ratio: 61.59
Exchange: BSE
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 209.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 9
DGR3: 17.66%
DGR5: 30.00%